Yu Jian

Ms. Yu Jian

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
YJYu Jian
Yu Jian
HWHong Wang
Hong Wang
MZMeijing Zhou
Meijing Zhou
MZMin Zhu
Min Zhu
JHJing Hang
Jing Hang
TYTao Yang
Tao Yang
Aims: To put forward a scientific hypothesis about the progression of insulin-injection-induced lipohypertrophy (LH) according to the high-frequency ultrasonic imaging of insulin injection sites and the blood glucose control of patients. Methods: A total of 344 patients were screened for LH by means of high-frequency ultrasound scanning. The results of their ultrasound examination were described in detail and categorized into several subtypes. Seventeen patients with different subtypes of LH were followed up to predict the progression of LH. To further verify our hypothesis, the effects of different types of LH on glycemic control of patients were observed by comparing glycated hemoglobin A1c (HbA1C) and other glycemic-related indicators. Results: LH was found in 255 (74.1%) patients. According to the high-frequency ultrasonic imaging characteristics, LH can be categorized into three subtypes in general. Among all the LHs, the most common type observed was nodular hyperechoic LH (n = 167, 65.5%), followed by diffuse hyperechoic LH (n = 70, 27.5%), then hypoechoic LH (n = 18, 7.0%). At the follow-up after six months, all 10 patients with nodular hyperechoic LH had LH faded away. Of the five patients with diffuse hyperechoic LH, two had inapparent LH, and three had diffuse hyperechoic parts which had shrunk under ultrasound. No obvious changes were observed in the two cases of hypoechoic LH. Compared with the LH-free group, the mean HbA1C of the nodular hyperechoic LH group increased by 0.8% (9 mmol/mol) (95% CI:−1.394~−0.168, p = 0.005), that of the diffuse hyperechoic LH group increased by 2.0% (21 mmol/mol) (95% CI: −2.696~−1.20, p < 0.001), and that of the hypoechoic LH group increased by 1.5% (16 mmol/mol) (95% CI: −2.689~−0.275, p = 0.007). Conclusions: It was hypothesized that the earlier stage of LH is nodular hyperechoic LH. If nodular LH is not found in time and the patient continues to inject insulin at the LH site and/or reuse needles, LH will develop into a diffuse type or, even worse, a hypoechoic one. Different subtypes of LH may represent differences in severity when blood glucose control is considered as an important resolution indicator. Further studies are needed to confirm our hypothesis on the progression and reversion of insulin-induced lipohypertrophy.

18 October 2023 in Endocrine Practice
Verified
Journal Article
Closed access
YJYu Jian
Yu Jian
BXBei Xu
Bei Xu
GMGuodong Ma
Guodong Ma
YLYuqing Liu
Yuqing Liu
YYYuhong Yang
Yuhong Yang
MSMin Sun
Min Sun

2 April 2025 in Diabetic Medicine
Verified
Journal Article
Closed access
YJYu Jian
Yu Jian
HWHong Wang
Hong Wang
MZMeijing Zhou
Meijing Zhou
MZMin Zhu
Min Zhu
JHJing Hang
Jing Hang
JXJingjing Xu
Jingjing Xu

19 November 2025 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
JZJufeng Zhang
Jufeng Zhang
MGMingjie Gu
Mingjie Gu
ZCZhimei Chen
Zhimei Chen
JFJiahui Fu
Jiahui Fu
YJYu Jian
Yu Jian
Malnutrition in older non-small cell lung cancer (NSCLC) patients undergoing chemotherapy correlates with poor outcomes. While nutritional risk is dynamic, longitudinal trajectory patterns remain uncharacterized in this population. The present study aimed to explore the trajectory subgroups and influencing factors of nutrition-related risk over time among older adults with advanced NSCLC undergoing first-line chemotherapy. A retrospective longitudinal study. In total, 353 patients aged > 60 years who were diagnosed with advanced NSCLC and received at least six cycles of chemotherapy at a single tertiary oncology center between January 2022 and June 2024 were enrolled in this study. Nutrition-related risk was assessed with Geriatric Nutritional Risk Index (GNRI). The trajectory subgroups of nutrition-related risk over time were analyzed using the latent class growth modeling (LCGM). An unordered multi-class logistic regression analysis was performed to find the influencing factors of different trajectories. The average age of 353 patients was (68.2 ± 6.1) years, among which 272 (77.1%) were male. According to LCGM, the three categories of nutrition-related risk trajectories were identified, which were stable low risk group (n = 188, 53.3%), improving moderate risk group (n = 124, 35.1%), and persistent high to moderate risk group (n = 41, 11.6%). Unordered multi-class logistic regression analysis showed that age, smoking status, and hypertension were associated with the trajectory categories of nutrition-related risks. Nutrition risk follows distinct trajectories during chemotherapy cycles, with 11.6% of older adults with NSCLC exhibiting sustained high vulnerability. Older age, smoking history, and hypertension are key predictors of this adverse trajectory. Assessment of these readily available and easily accessible clinical factors at treatment initiation may enable early identification of high-risk patients for targeted nutritional interventions.

1 May 2024 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
YJYu Jian
Yu Jian
HWHong Wang
Hong Wang
MZMin Zhu
Min Zhu
MZMeijing Zhou
Meijing Zhou
JXJingjing Xu
Jingjing Xu
Objective: This study aimed to explore the stable longitudinal patient-centered self-protective factors of glycosylated hemoglobin (HbA1c) in adolescents with type 1 diabetes mellitus (T1DM). Methods: We used both cross-sectional and longitudinal datasets at the Diabetes Education Center and National Endocrine and Metabolism Centre of a university hospital in China from April 2020 to July 2022. Participants were assessed using the Adolescent Diabetic Behavior Rating Scale (DBRS), Diabetes Strengths and Resilience Measure for Adolescents (DSTAR-Teen). HbA1c and other clinical variables were obtained from the medical record at the same time. 266 adolescents (131 male, age 14.1± 3.9 years) completed the cross-sectional assessments and 131 (62 male, age 14.6± 3.3 years) participated in a follow-up at a 1-year visit interval. Results: Logistic regression analysis of cross-sectional data of 266 cases showed that there were significant positive effects between pump treatment (β=0.090, OR 2.460, P=0.005), DBRS scores (β=2.593, OR 13.366, P=0.002) and the meeting of standard HbA1c (< 7.5%, 58 mmol/mol). Disease duration (β=− 0.071, OR 0.932, P=0.033) was negatively correlated with it. The longitudinal multivariate generalized estimation equation model showed that DBRS scores (β=3.165, OR 23.681, P=0.009) and DSTAR-Teen scores (β=0.050, OR 1.051, P=0.012) had a positive influence on the meeting of standard HbA1c over one year time of 131 cases. Conclusion: Self-care and resilience had higher cross-temporal stability in influencing glycemic control over time. To reach a better glycemic control and improve long-term health outcomes, attention should be paid to the detection and enhancement of these patient-centered promoters.

1 February 2017 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
ESEric C Sorenson
Eric C Sorenson
ACAruj J Choudhry
Aruj J Choudhry
YJYu Jian
Yu Jian
SRSanjay S. Reddy
Sanjay S. Reddy
CDCrystal Denlinger
Crystal Denlinger
ESElin R. Sigurdson
Elin R. Sigurdson
697 Background: A major challenge in identifying candidates for nonoperative management of locally advanced rectal cancer is predicting pathological complete response (pCR) following chemoradiation therapy (CRT). We evaluated the ability of pre- and post-CRT PET imaging to predict pCR and long-term prognosis. Methods: We retrospectively identified patients at our institution from 2002–2015 with locally advanced rectal cancer who underwent CRT, pre- and post-CRT PET imaging, and surgical resection. Logistic regression and Kaplan-Meier estimates were used to analyze the association of PET variables with tumor pCR and survival outcomes. Receiver operator characteristic curves were generated to define optimal cutoff points for predictive PET variables. Results: 140 patients matched the inclusion criteria. The pCR rate was 28%, and median follow-up time was 48 months. On multivariable analysis, pCR was associated with lower median post-CRT SUVmax(3.2 vs 5.2, p=0.009) and higher median SUV percent decrease (72 vs 58%, p=0.009). ROC curves were generated for SUV percent decrease (AUC=0.70) and post-CRT SUV (AUC=0.69) to estimate cutoff points for maximum specificity and sensitivity to predict pCR. Post-CRT SUV 66% were equally predictive of pCR with a sensitivity of 65%, specificity of 72%, PPV of 44%, and NPV of 86%. Median 5-year OS and RFS were significantly improved for patients with post-CRT SUV 66% (OS, 82 vs 66%, p=0.05; RFS, 75 vs 54%, p=0.01). Patients with stage III disease and a post-CRT SUV <4.3 were in effect downstaged, with a median 5-year OS equivalent to that of patients with stage II disease (Table 1; 86 vs 86%). Conclusions: PET/CT may be a useful modality in predicting pCR and overall survival in patients undergoing CRT for rectal cancer. Inclusion of pre-CRT PET does not appear to add prognostic value for pCR compared with post-CRT PET alone. Patients with a post-CRT SUV of >4.3 should not be considered for nonoperative management, as an estimated 86% of these patients will not have a pCR.